Latest filing: Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Vaishali Pharma Limited
ObservedCompany dossier
Vaishali Pharma
NSE:VAISHALI · ISIN INE972X01022
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Vaishali Pharma
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹27.9 Cr · PAT ₹1.4 Cr.
Exchange XBRLLatest ownership: promoter group 30.54% and public 69.46% as of 03 Jul 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Archived filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Vaishali Pharma Limited
NSE · exchange filing
Observed
Archived filing Outcome of Board Meeting - Vaishali Pharma Limited
NSE · financial results
Observed
Source filing Shareholders meeting - Vaishali Pharma Limited
NSE · exchange filing
Observed
Source filing Allotment of Securities - Vaishali Pharma Limited
NSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹27.9 Cr
- Profit after tax
- ₹1.4 Cr
- EPS
- ₹0.98
Observed NSE structured filing · Non-Consolidated
Ownership
Full shareholding →03 Jul 2026
- Promoter group
- 30.54%
- Public
- 69.46%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL